Anebulo annual meeting: directors elected, stock plan amended with 2M additional shares, auditor ratified

Anebulo Pharmaceuticals, Inc.

Stockholders elected three Class I directors: Joseph Lawler, Daniel Schneebeger, Aron English.
Amendment to 2020 Stock Incentive Plan approved, increasing authorized shares by 2,000,000 to 3,650,000 (13.55M for, 69K against).
Appointment of EisnerAmper LLP as independent auditor for FY2022 ratified (14,080,531 for, 0 against, 737 abstain).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.